TCR2 Therapeutics (TCRR) Earnings
|
Expand Research on TCRR
| Next EPS Date | N/A | EPS Growth Rate | N/A |
|---|---|---|---|
| Average EPS % Beat Rate | -5.1% | Revenue Growth Rate | N/A |
| Average % Move 1-Wk after EPS | +3.8% | Normal Earnings Time | Before Open |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 8/9/23 | Q223 | N/A | -$0.75 | N/A | N/A | N/A | N/A | N/A | N/A | ||
| 5/17/23 | Q123 | N/A | -$0.77 | N/A | N/A | N/A | N/A | N/A | N/A | ||
| 5/11/23 | Q123 | -$1.03 | -$0.77 | -$0.26 | N/A | N/A | N/A |  | | Details | |
| 4/3/23 | Q422 | N/A | -$0.81 | N/A | N/A | N/A | N/A | N/A | N/A | ||
| 11/16/22 | Q322 | N/A | -$0.78 | N/A | N/A | N/A | N/A | N/A | N/A | ||
| 8/8/22 | Q222 | -$0.64 | -$0.78 | +$0.14 | N/A | N/A | N/A | | | Details | |
| 8/12/20 | Q220 | -$0.67 | -$0.64 | -$0.03 | N/A | N/A | N/A | | | Details | |
| 5/13/19 |  |
Q119 | -$4.85 | N/A | N/A | N/A | N/A | N/A | | | Details |
